Also found in: Medical, Encyclopedia.


An apparatus, such as a fermentation chamber, for growing organisms such as bacteria or yeast that are used in the biotechnological production of substances such as pharmaceuticals, antibodies, or vaccines, or for the bioconversion of organic waste.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.


(Biology) a machine for growing organisms
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014


(ˌbaɪ oʊ riˈæk tər)

a fermentation vat for the production of living organisms, as bacteria or yeast.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
The Solid Waste Division also will construct a leachate handling and storage system as a part of the bioreactor landfill cell construction.
The Mobius 2000 Liter Single-Use Bioreactor is a stirred tank bioreactor that provides flexibility by configuring software, hardware, and single-use assemblies for use in suspension and adherent cell-culture applications for drug manufacturing.
Their topics are a novel see-saw bioreactor; simulating bioprocess and the development of BIPROSIM, a general purpose simulation program; the dynamic optimization of a bioprocess using a genetic algorithm; bioprocesses and time delay control; experimentation on the bioreactors; and the future scope of research.
DOST-National Capital Region (NCR) partnered with UP for the first academic application of the biomass reactor (bioreactor) in the project dubbed "Pioneering the Employment of Locally-Developed Technology Using the 500 kg/day ITDI-DOST Bioreactor Technology in Academic Set-up."
Summary: The growth of bioreactors in Pharmaceutical Sector and technological advancements in bioreactors, and adoption of single-use bioreactors (SUBs) and hybrid bioreactors are the prime factors responsible for the growth of the bioreactor market currently.
Sartorius Stedim Biotech (SSB) has launched the BIOSTAT RM TX single-use bioreactor, a new wave mixed system developed specifically for closed, automated expansion of consistent quality cell products such as ex vivo cellular immunotherapies.
The Copenhagen facility will add a Single-use Bioreactor (SUB) 6Pack suite, consisting of six 2000L production bioreactors and a 2000L seed train.
This Copenhagen facility will add a Single-use Bioreactor (SUB) six Pack suite that consist of six 2000l production bioreactors and a 2000l seed train.The proprietary bioreactor configuration will enable flexible, innovative and customized cGMP production capabilities, offering scales from 2000l to 12000l in a single run.
It implements the pioneering approach of combining multiple 2,000L bioreactor harvests to allow production runs to reach either 6,000L or 12,000L, a strategy that was executed under an accelerated construction timeline, at significantly lower CAPEX, and with the elimination of bioreactor scale-up challenges.
Sartorius Stedim Biotech launched a new mini bioreactor vessel for its ambr 250 high-throughput (ht) system, designed for optimal growth of adherent cells on microcarriers to enable rapid, scalable cell culture process development of vaccines.
The 4,000L CSR is the largest single-use bioreactor size available in the industry and potentially largest-ever design in conventional disposable bioreactors, resulting in higher productivity and significantly lowering the cost of goods for cell culture-based biopharmaceuticals.